Inventor · disambiguated record
David L. Porter
Also filed as: PORTER DAVID L
17 granted patents·8 pending applications·3,065 citations·filing 2011–2024
97Inventor score
Top patents by PatentIndex Score
25 records- 0199US9540445B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Jan 10, 2017·99 cites·30 claims
- 0299US9518123B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Dec 13, 2016·92 cites·26 claims
- 0399US9481728B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2015·Granted Nov 1, 2016·100 cites·30 claims
- 0499US9464140B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Oct 11, 2016·117 cites·28 claims
- 0599US9328156B2Use of chimeric antigen receptor-modified T cells to treat cancerUNIV PENNSYLVANIA·Filed 2013·Granted May 3, 2016·127 cites·15 claims
- 0699US9102761B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0799US9102760B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·254 cites·30 claims
- 0899US9101584B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0999US8975071B1Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Mar 10, 2015·255 cites·17 claims
- 1099US8916381B1Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Dec 23, 2014·276 cites·28 claims
- 1199US8911993B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 16, 2014·474 cites·21 claims
- 1299US8906682B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 9, 2014·507 cites·30 claims
- 1398US9499629B2Use of chimeric antigen receptor-modified T-cells to treat cancerJUNE CARL H·Filed 2011·Granted Nov 22, 2016·151 cites·53 claims
- 1497US9815901B2Treatment of cancer using a CD123 chimeric antigen receptorBROGDON JENNIFER·Filed 2015·Granted Nov 14, 2017·94 cites·40 claims
- 1595US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 1683US10703819B2Treatment of cancer using a CD123 chimeric antigen receptorNOVARTIS AG·Filed 2017·Granted Jul 7, 2020·1 cites·33 claims
- 1779US2023220090A1Treatment of cancer using a cd123 chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1875US2025163123A1Therapeutic regimens for chimeric antigen receptor (car)-expressing cellsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1970US11591404B2Treatment of cancer using a CD123 chimeric antigen receptorNOVARTIS AG·Filed 2020·Granted Feb 28, 2023·0 cites·33 claims
- 2069US2018258391A1Compositions and Methods for Treatment of CancerUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 2167US2017283775A1Compositions and Methods for Treatment of CancerUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 2262US2019388471A1Treatment of cancer using anti-cd19 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2353US2021177896A1Therapeutic regimens for chimeric antigen receptor (car)- expressing cellsPORTER DAVID L·Filed 2017·Application pending·0 cites
- 2451US2021347851A1Cd19 chimeric antigen receptor (car) and cd22 car combination therapiesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2533US2018140602A1Combination of chimeric antigen receptor therapy and amino pyrimidine derivativesANGST DANIELA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David L. Porter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →